Minkyung Han Selected Research

Minkyung Han Research Topics

Disease

8	Rheumatoid Arthritis 07/2023 - 07/2014
4	Tuberculosis (Tuberculoses) 05/2024 - 02/2013
4	Neoplasms (Cancer) 01/2023 - 01/2017
3	Crohn Disease (Crohn's Disease) 01/2021 - 01/2020
3	Ulcerative Colitis 05/2020 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 01/2023 - 08/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 08/2021
2	Stroke (Strokes) 01/2022 - 01/2021
1	COVID-19 10/2023
1	Atrial Fibrillation 07/2023
1	Infectious Arthritis (Septic Arthritis) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Diabetes Mellitus 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Ankylosing Spondylitis 01/2023
1	Dementia (Dementias) 01/2022
1	Latent Tuberculosis 01/2022
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2021
1	Schizophrenia (Dementia Praecox) 12/2021
1	Hepatitis B 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Fibrosis (Cirrhosis) 04/2021
1	Chronic Hepatitis B 04/2021
1	Endometriosis 01/2021
1	Infections 01/2021
1	Knee Osteoarthritis 01/2021
1	Microscopic Polyangiitis 01/2021
1	Vasculitis (Vasculitides) 11/2019
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2019
1	Pancreatitis 11/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2019
1	Osteoporosis 07/2014
1	Rheumatic Diseases (Rheumatism) 02/2013

Drug/Important Bio-Agent (IBA)

4	Antirheumatic Agents (DMARD)IBA 07/2023 - 01/2017
4	Infliximab (Remicade)FDA Link 01/2023 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2020
3	Adalimumab (Humira)FDA Link 01/2021 - 01/2020
2	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 01/2022
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2021
2	mizoribineIBA 01/2021 - 11/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 11/2019
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 11/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 11/2019
2	Azathioprine (Imuran)FDA LinkGeneric 01/2021 - 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	SteroidsIBA 10/2023
1	Thyroid HormonesIBA 01/2023
1	Etanercept (Enbrel)FDA Link 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	Proton Pump InhibitorsIBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Haloperidol (Haldol)FDA LinkGeneric 12/2021
1	Antipsychotic Agents (Antipsychotics)IBA 12/2021
1	Clozapine (Clozaril)FDA LinkGeneric 12/2021
1	IodineIBA 08/2021
1	Transaminases (Aminotransferases)IBA 04/2021
1	Alanine Transaminase (SGPT)IBA 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 04/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	CalciumIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	golimumab FDA Link 01/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2019
1	Immunologic Factors (Immunomodulators)IBA 07/2019
1	GlucocorticoidsIBA 07/2014
1	Tuberculin (PPD)IBA 02/2013
1	GoldIBA 02/2013

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2020
2	Appendectomy 05/2024 - 01/2021
1	Thyroidectomy 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Patient Care 01/2022
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021
1	Complementary Therapies (Alternative Medicine) 11/2015